Literature DB >> 32449654

How Should Shared Decision Making Be Taught?

Dong-Kha Tran1, Peter Angelos2.   

Abstract

As the field of medicine shifts from a paternalistic to a more patient-centered orientation, the dynamics of shared decision making become increasingly complicated. International globalization and national socioeconomic differences have added unintended difficulties to culturally sensitive communication between physician and patient, which can contribute to the growing erosion of clinician empathy. This article offers a strategy for teaching students how to enter into conversations about shared decision making by bolstering their empathy as a result of exposing them to the many variables outside of their patients' control. Patients' historical and cultural context, gender identity, sexual orientation, and common assumptions about clinicians as well as institutional biases can severely limit students' ability to integrate patients' value-laden preferences into shared decision making about health care.
© 2020 American Medical Association. All Rights Reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32449654     DOI: 10.1001/amajethics.2020.388

Source DB:  PubMed          Journal:  AMA J Ethics


  2 in total

1.  Validation of an Arabic Version of the Self-Efficacy for Appropriate Medication Use Scale.

Authors:  Hawazin Alhazzani; Ghaida AlAmmari; Nouf AlRajhi; Ibrahim Sales; Amr Jamal; Turky H Almigbal; Mohammed A Batais; Yousif A Asiri; Yazed AlRuthia
Journal:  Int J Environ Res Public Health       Date:  2021-11-15       Impact factor: 3.390

Review 2.  Informed Consent for Intraoperative Neural Monitoring in Thyroid and Parathyroid Surgery - Consensus Statement of the International Neural Monitoring Study Group.

Authors:  Che-Wei Wu; Tzu-Yen Huang; Gregory W Randolph; Marcin Barczyński; Rick Schneider; Feng-Yu Chiang; Amanda Silver Karcioglu; Beata Wojtczak; Francesco Frattini; Patrizia Gualniera; Hui Sun; Frank Weber; Peter Angelos; Henning Dralle; Gianlorenzo Dionigi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-07       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.